These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16357599)

  • 1. Estrogen metabolism and breast cancer.
    Kabat GC; O'Leary ES; Gammon MD; Sepkovic DW; Teitelbaum SL; Britton JA; Terry MB; Neugut AI; Bradlow HL
    Epidemiology; 2006 Jan; 17(1):80-8. PubMed ID: 16357599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women.
    Ursin G; London S; Stanczyk FZ; Gentzschein E; Paganini-Hill A; Ross RK; Pike MC
    J Natl Cancer Inst; 1999 Jun; 91(12):1067-72. PubMed ID: 10379970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary estrogen metabolites and breast cancer: a combined analysis of individual level data.
    Dallal CM; Stone RA; Cauley JA; Ness RB; Vogel VG; Fentiman IS; Fowke JH; Krogh V; Loft S; Meilahn EN; Muti P; Olsen A; Overvad K; Sieri S; Tjønneland A; Ursin G; Wellejus A; Taioli E
    Int J Biol Markers; 2013 Apr; 28(1):3-16. PubMed ID: 22865302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary estrogen metabolites and breast cancer: a case-control study.
    Kabat GC; Chang CJ; Sparano JA; Sepkovie DW; Hu XP; Khalil A; Rosenblatt R; Bradlow HL
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):505-9. PubMed ID: 9232337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women.
    Muti P; Bradlow HL; Micheli A; Krogh V; Freudenheim JL; Schünemann HJ; Stanulla M; Yang J; Sepkovic DW; Trevisan M; Berrino F
    Epidemiology; 2000 Nov; 11(6):635-40. PubMed ID: 11055622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ratio of the estradiol metabolites 2-hydroxyestrone (2-OHE1) and 16α-hydroxyestrone (16-OHE1) may predict breast cancer risk in postmenopausal but not in premenopausal women: two case-control studies.
    Ruan X; Seeger H; Wallwiener D; Huober J; Mueck AO
    Arch Gynecol Obstet; 2015 May; 291(5):1141-6. PubMed ID: 25318606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women.
    Ursin G; London S; Yang D; Tseng CC; Pike MC; Bernstein L; Stanczyk FZ; Gentzschein E
    Breast Cancer Res Treat; 2002 Mar; 72(2):139-43. PubMed ID: 12038704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.
    Ursin G; London S; Stanczyk FZ; Gentzschein E; Paganini-Hill A; Ross RK; Pike MC
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):601-5. PubMed ID: 9168002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collection.
    Fowke JH; Qi D; Bradlow HL; Shu XO; Gao YT; Cheng JR; Jin F; Zheng W
    Steroids; 2003 Jan; 68(1):65-72. PubMed ID: 12475724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating estrogen metabolites and risk of breast cancer in postmenopausal women.
    Arslan AA; Koenig KL; Lenner P; Afanasyeva Y; Shore RE; Chen Y; Lundin E; Toniolo P; Hallmans G; Zeleniuch-Jacquotte A
    Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1290-7. PubMed ID: 24769889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis.
    Barba M; Yang L; Schünemann HJ; Sperati F; Grioni S; Stranges S; Westerlind KC; Blandino G; Gallucci M; Lauria R; Malorni L; Muti P
    J Exp Clin Cancer Res; 2009 Oct; 28(1):135. PubMed ID: 19814782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen metabolites and the risk of breast cancer in older women.
    Cauley JA; Zmuda JM; Danielson ME; Ljung BM; Bauer DC; Cummings SR; Kuller LH
    Epidemiology; 2003 Nov; 14(6):740-4. PubMed ID: 14569192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating estrogen metabolites and risk for breast cancer in premenopausal women.
    Arslan AA; Shore RE; Afanasyeva Y; Koenig KL; Toniolo P; Zeleniuch-Jacquotte A
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2273-9. PubMed ID: 19661086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal women.
    Riza E; dos Santos Silva I; De Stavola B; Bradlow HL; Sepkovic DW; Linos D; Linos A
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):627-34. PubMed ID: 11401912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk.
    Ho GH; Luo XW; Ji CY; Foo SC; Ng EH
    Ann Acad Med Singap; 1998 Mar; 27(2):294-9. PubMed ID: 9663330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants in estrogen metabolism and biosynthesis genes and urinary estrogen metabolites in women with a family history of breast cancer.
    Greenlee H; Chen Y; Kabat GC; Wang Q; Kibriya MG; Gurvich I; Sepkovic DW; Bradlow HL; Senie RT; Santella RM; Ahsan H
    Breast Cancer Res Treat; 2007 Mar; 102(1):111-7. PubMed ID: 16850246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary estrogen metabolites and prostate cancer: a case-control study in the United States.
    Muti P; Westerlind K; Wu T; Grimaldi T; De Berry J; Schünemann H; Freudenheim JL; Hill H; Carruba G; Bradlow L
    Cancer Causes Control; 2002 Dec; 13(10):947-55. PubMed ID: 12588091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation of urinary estrogen metabolites with mammographic densities in premenopausal women.
    Maskarinec G; Heak S; Morimoto Y; Custer L; Franke AA
    Cancer Epidemiol; 2012 Oct; 36(5):e310-6. PubMed ID: 22537763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying estrogen metabolism: an evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16alpha-hydroxyestrone in urine.
    Ziegler RG; Rossi SC; Fears TR; Bradlow HL; Adlercreutz H; Sepkovic D; Kiuru P; Wahala K; Vaught JB; Donaldson JL; Falk RT; Fillmore CM; Siiteri PK; Hoover RN; Gail MH
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):607-14. PubMed ID: 9168003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new ELISA kit for measuring urinary 2-hydroxyestrone, 16alpha-hydroxyestrone, and their ratio: reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acid.
    Falk RT; Rossi SC; Fears TR; Sepkovic DW; Migella A; Adlercreutz H; Donaldson J; Bradlow HL; Ziegler RG
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):81-7. PubMed ID: 10667467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.